THERAPEUTIC HYDROGELS
The present disclosure pertains to therapeutic hydrogels that comprise an anionic polysaccharide crosslinked by a branched polyamine, wherein the branched polyamine comprises at least two primary amine groups, more typically at least three primary amine groups. The present disclosure also pertains t...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
06.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure pertains to therapeutic hydrogels that comprise an anionic polysaccharide crosslinked by a branched polyamine, wherein the branched polyamine comprises at least two primary amine groups, more typically at least three primary amine groups. The present disclosure also pertains to medical compositions that comprise such therapeutic hydrogels and to methods of medical treatment in which such therapeutic hydrogels are delivered to a patient in need of medical treatment. |
---|---|
Bibliography: | Application Number: US202217713596 |